Furthermore, impaired NaCT function prevents high-fat diet-induced insulin resistance, alters lipid metabolism [36,79], and correlates with the outcomes of NAFLD patients [14]. The gene discussed is SLC13A5; the disease is metabolic dysfunction-associated steatotic liver disease.